Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01894906 · ClinicalTrials.gov registry record · Phase 1
Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients
A Phase 1 study, sponsored by Rockwell Medical Technologies.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01894906 is a Phase 1 study that has completed, run by Rockwell Medical Technologies. The registered enrollment target is 12 participants.
The verdict
NCT01894906, a Phase 1 study, has completed, sponsored by Rockwell Medical Technologies.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the quantity of iron derived from SFP that is transferred from the dialysate to patients during a single dialysis session. The effects of various conditions which may affect the transfer of iron such as blood and dialysate flow rate, changes in bicarbonate delivery, dialyzer membrane type and the effect of reuse will also be investigated. The absorption and removal of iron from the blood will also be investigated.
Interventions
- OTHER Placebo
- DRUG Soluble Ferric Pyrophosphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-07 |
| Est. Completion | 2013-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01894906
The ClinicalTrials.gov registry entry for NCT01894906 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockwell Medical Technologies, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01894906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01894906 about?
NCT01894906 is a clinical study titled "Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients". The purpose of this study is to determine the quantity of iron derived from SFP that is transferred from the dialysate to patients during a single dialysis session. The effects of various conditions which may affect the transfer of iron such as blood and dialysate flow rate, changes in bicarbonate d...
What is the current status of trial NCT01894906?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2013-07. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01894906?
The interventions under investigation include: Placebo (OTHER), Soluble Ferric Pyrophosphate (DRUG).
Who is sponsoring clinical trial NCT01894906?
This trial is sponsored by Rockwell Medical Technologies, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.